PSMC2 promotes resistance against temozolomide in glioblastoma via suppressing JNK-mediated autophagic cell death
Authors:
- 15 January 2025
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 233, 116755
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Mitophagy at the crossroads of cancer development: Exploring the role of mitophagy in tumor progression and therapy resistanceBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2024
- MGMT in TMZ-based glioma therapy: Multifaceted insights and clinical trial perspectivesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2024
- A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistanceBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2023
- An overview of kinin mediated events in cancer progression and therapeutic applicationsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2022
- An insight into the ubiquitin-proteasomal axis and related therapeutic approaches towards central nervous system malignanciesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2022
- Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019JAMA Oncology, 2021
- CN‐3 increases TMZ sensitivity and induces ROS‐dependent apoptosis and autophagy in TMZ‐resistance glioblastomaJournal of Biochemical and Molecular Toxicology, 2021
- Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancerBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2019
- Targeting autophagy for combating chemoresistance and radioresistance in glioblastomaApoptosis, 2018
- ER stress-induced cell death mechanismsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2013